1. Anon, FDA's Policy Statement for the Development of New Stereoisomeric Drugs, U.S. Food and Drug Administration Guidance, Washington, DC (1992).
2. Anon, Market Trends in Chiral Separations, Universal Pharma Technologies LLC Report, North Andover, MA (1997).
3. Winning at New Products, Second Edition, Addison-Wesley, Reading, MA (1993).
4. Biotransformations in Organic Chemistry, Third Edition, Springer-Verlag, Berlin (1997).
5. The Same and Not the Same, Columbia University Press, New York (1997).